Revalia Bio, Inc. — Form D
Revalia Bio, Inc. of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2024-11-06. The offering totals $17.0M, of which $12.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-11-06
- Form: D
- Accession: 0002043834-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $12.3M
- Remaining: $4.7M
- Investors: 32
- Date of first sale: 2024-10-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-528748
Issuer
- Name: Revalia Bio, Inc.
- CIK: 0002043834
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 55 CHURCH STREET, NEW HAVEN, CT, 06510
- Phone: (312) 520-8301
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Milad T Alucozai | Director | West Lafayette, IN |
| Gregory T Tietjen | Director | New Haven, CT |
| Brian T Wilcove | Director | San Francisco, CA |
| Gregory T Tietjen | Executive Officer | New Haven, CT |
More